表紙SALE
市場調查報告書
商品編碼
1027923

滴眼液市場預測/競爭趨勢/增長機會(~ 2026 年):按類型/藥物類別/適應症/分銷渠道/最終用戶/地區

Global Eye Drop Market By Type, By Drug Class, By Disease Indication, By Distribution Channel, By End User, By Region, Competition, Forecast & Opportunities, 2026

出版日期: | 出版商: TechSci Research | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

  • 全貌
  • 簡介
  • 目錄
簡介

在全球眼藥水市場,消費者越來越意識到眼部護理的重要性、數碼設備的普及、白內障等眼科手術後需要滴眼藥水的增加,以及易患眼病的老年人眼病。由於人口增加等因素,預計在預測期內會出現顯著增長。

本報告探索全球眼藥水市場,定義和概述市場,分析新型冠狀病毒感染(COVID-19)和其他市場影響因素,分析客戶反饋和市場規模。趨勢/預測、類型/藥物類別/適應症/分銷渠道/按最終用戶細分,按地區/主要國家、競爭環境、市場份額、主要公司簡介等進行詳細分析。

目錄

第 1 章產品概述

第二章調查方法

第 3 章 COVID-19 的影響

第 4 章執行摘要

第五章客戶反饋

第 6 章世界市場展望

  • 市場規模/預測
  • 市場份額/預測
    • 按類型
      • 處方
      • 場外交易
    • 按藥物類別
      • 抗過敏
      • 抗炎
      • 抗青光眼
      • 抗 VEGF
      • 其他
    • 按指示
      • 青光眼
      • 眼睛過敏
      • 眼部感染
      • 視網膜病變
      • 其他
    • 按分銷渠道
      • 醫院藥房
      • 零售藥店
      • 網上藥店
    • 最終用戶
      • 醫院/診所
      • 家庭護理
      • 其他
    • 按公司
    • 按地區
  • 產品市場地圖

第七章亞太市場分析/預測

  • 市場規模/預測
  • 市場份額/預測
    • 按類型
    • 按藥物類別
    • 按指示
    • 按分銷渠道
    • 最終用戶
    • 按國家/地區

第八章歐洲市場分析與預測

  • 市場規模/預測
  • 市場份額/預測
    • 按類型
    • 按藥物類別
    • 按指示
    • 按分銷渠道
    • 最終用戶
    • 按國家/地區

第九章北美市場分析與預測

  • 市場規模/預測
  • 市場份額/預測
    • 按類型
    • 按藥物類別
    • 按指示
    • 按分銷渠道
    • 最終用戶
    • 按國家/地區

第10章南美市場分析/預測

  • 市場規模/預測
  • 市場份額/預測
    • 按類型
    • 按藥物類別
    • 按指示
    • 按分銷渠道
    • 最終用戶
    • 按國家/地區

第11章中東和非洲市場分析與預測

  • 市場規模/預測
  • 市場份額/預測
    • 按類型
    • 按藥物類別
    • 按指示
    • 按分銷渠道
    • 最終用戶
    • 按國家/地區

第 12 章市場動態

  • 促進因素
  • 挑戰

第 13 章市場趨勢

第14章競爭形勢

  • Johnson & Johnson
  • Bausch Health Companies, Inc.
  • Abbott Laboratories, Inc.
  • Alcon Inc.
  • Allergan, Inc.(AbbVie)
  • Bayer Corporation
  • Genentech, Inc.(Roche)
  • Akorn, Inc.
  • KC Pharmaceuticals, Inc.
  • Pfizer, Inc.

第15章 策略建議

第16章 關於出版商&免責事項

目錄
Product Code: 4539

Global eye drop market is expected to register a substantial growth during the forecast period owing to factors like rising awareness among people about importance of eye care, high adoption of digital devices, rise in number of cataract and other eye-related surgeries that require the use of eye drops after surgeries and increase in geriatric population who are more prone to suffer from eye diseases.

Eye drops are used to relieve people suffering from various eye problems such as eye dryness, redness, infection (pink eye), allergies, itching, soreness, swelling, and others. Increase in number of working populations is also leading to several forms of illness including hormonal imbalances. Imbalance in hormone levels also leads to eye and vision problems. Thus, eye drops and lubricants come to rescue as they are handier, less painful and are can be used for various eye problems.

The global eye drop market is segmented based on type, drug class, disease indication, distribution channel, end user, region and company. Based on distribution channel, the market can be categorized into hospital pharmacy, retail pharmacy and online pharmacy. The retail pharmacy segment is expected to dominate the market owing to the convenience of getting different medications at retail pharmacies.

Major players operating in the global eye drop market include Johnson & Johnson, Bausch Health Companies, Inc., Abbott Laboratories, Inc., Alcon Inc., Allergan, Inc. (AbbVie), Bayer Corporation, Genentech, Inc. (Roche), Akorn, Inc., KC Pharmaceuticals, Inc., Pfizer, Inc. and others.

Years considered for this report:

  • Historical Years: 2016-2019
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Period: 2022-2026

Objective of the Study:

  • To analyze and forecast the market size of global eye drop market.
  • To classify and forecast global eye drop market based on type, drug class, disease indication, distribution channel, end user, company and regional distribution.
  • To identify drivers and challenges for global eye drop market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global eye drop market.
  • To identify and analyze the profile of leading players operating in global eye drop market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global eye drop market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Eye drop manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to eye drops
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global eye drop market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Eye Drop Market, By Type:

Prescription

Over-The-Counter

  • Global Eye Drop Market, By Drug Class:

Antiallergy

Anti-inflammatory

Antiglaucoma

Anti-VEGF

Others

  • Global Eye Drop Market, By Disease Indication:

Dry Eye Diseases

Glaucoma

Eye Allergy

Eye Infections

Retinal Disorders

Others

  • Global Eye Drop Market, By Distribution Channel:

Hospitals Pharmacy

Retail Pharmacy

Online Pharmacy

  • Global Eye Drop Market, By End User:

Hospitals & Clinics

Homecare

Others

  • Global Eye Drop Market, By Region:

Asia-Pacific

Europe

North America

South America

Middle East

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global eye drop market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Eye Drop Market

4. Executive Summary

5. Voice of Customer

6. Global Eye Drop Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Prescription v/s Over-The-Counter)
    • 6.2.2. By Drug Class (Antiallergy, Anti-inflammatory, Antiglaucoma, Anti-VEGF, Others)
    • 6.2.3. By Disease Indication (Dry Eye Diseases, Glaucoma, Eye Allergy, Eye Infections, Retinal Disorders, Others)
    • 6.2.4. By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy)
    • 6.2.5. By End User (Hospitals & Clinics, Homecare, Others)
    • 6.2.6. By Company (2020)
    • 6.2.7. By Region
  • 6.3. Product Market Map

7. Asia-Pacific Eye Drop Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Drug Class
    • 7.2.3. By Disease Indication
    • 7.2.4. By Distribution Channel
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Eye Drop Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Drug Class
        • 7.3.1.2.3. By Disease Indication
        • 7.3.1.2.4. By Distribution Channel
        • 7.3.1.2.5. By End User
    • 7.3.2. India Eye Drop Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Drug Class
        • 7.3.2.2.3. By Disease Indication
        • 7.3.2.2.4. By Distribution Channel
        • 7.3.2.2.5. By End User
    • 7.3.3. Japan Eye Drop Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Drug Class
        • 7.3.3.2.3. By Disease Indication
        • 7.3.3.2.4. By Distribution Channel
        • 7.3.3.2.5. By End User
    • 7.3.4. South Korea Eye Drop Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Drug Class
        • 7.3.4.2.3. By Disease Indication
        • 7.3.4.2.4. By Distribution Channel
        • 7.3.4.2.5. By End User
    • 7.3.5. Australia Eye Drop Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Drug Class
        • 7.3.5.2.3. By Disease Indication
        • 7.3.5.2.4. By Distribution Channel
        • 7.3.5.2.5. By End User

8. Europe Eye Drop Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Drug Class
    • 8.2.3. By Disease Indication
    • 8.2.4. By Distribution Channel
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Eye Drop Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Drug Class
        • 8.3.1.2.3. By Disease Indication
        • 8.3.1.2.4. By Distribution Channel
        • 8.3.1.2.5. By End User
    • 8.3.2. Germany Eye Drop Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Drug Class
        • 8.3.2.2.3. By Disease Indication
        • 8.3.2.2.4. By Distribution Channel
        • 8.3.2.2.5. By End User
    • 8.3.3. United Kingdom Eye Drop Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Drug Class
        • 8.3.3.2.3. By Disease Indication
        • 8.3.3.2.4. By Distribution Channel
        • 8.3.3.2.5. By End User
    • 8.3.4. Italy Eye Drop Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Drug Class
        • 8.3.4.2.3. By Disease Indication
        • 8.3.4.2.4. By Distribution Channel
        • 8.3.4.2.5. By End User
    • 8.3.5. Spain Eye Drop Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Drug Class
        • 8.3.5.2.3. By Disease Indication
        • 8.3.5.2.4. By Distribution Channel
        • 8.3.5.2.5. By End User

9. North America Eye Drop Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Drug Class
    • 9.2.3. By Disease Indication
    • 9.2.4. By Distribution Channel
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Eye Drop Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Drug Class
        • 9.3.1.2.3. By Disease Indication
        • 9.3.1.2.4. By Distribution Channel
        • 9.3.1.2.5. By End User
    • 9.3.2. Mexico Eye Drop Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Drug Class
        • 9.3.2.2.3. By Disease Indication
        • 9.3.2.2.4. By Distribution Channel
        • 9.3.2.2.5. By End User
    • 9.3.3. Canada Eye Drop Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Drug Class
        • 9.3.3.2.3. By Disease Indication
        • 9.3.3.2.4. By Distribution Channel
        • 9.3.3.2.5. By End User

10. South America Eye Drop Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Drug Class
    • 10.2.3. By Disease Indication
    • 10.2.4. By Distribution Channel
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Eye Drop Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Drug Class
        • 10.3.1.2.3. By Disease Indication
        • 10.3.1.2.4. By Distribution Channel
        • 10.3.1.2.5. By End User
    • 10.3.2. Argentina Eye Drop Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Drug Class
        • 10.3.2.2.3. By Disease Indication
        • 10.3.2.2.4. By Distribution Channel
        • 10.3.2.2.5. By End User
    • 10.3.3. Colombia Eye Drop Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Drug Class
        • 10.3.3.2.3. By Disease Indication
        • 10.3.3.2.4. By Distribution Channel
        • 10.3.3.2.5. By End User

11. Middle East and Africa Eye Drop Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type
    • 11.2.2. By Drug Class
    • 11.2.3. By Disease Indication
    • 11.2.4. By Distribution Channel
    • 11.2.5. By End User
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Eye Drop Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Drug Class
        • 11.3.1.2.3. By Disease Indication
        • 11.3.1.2.4. By Distribution Channel
        • 11.3.1.2.5. By End User
    • 11.3.2. Saudi Arabia Eye Drop Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Drug Class
        • 11.3.2.2.3. By Disease Indication
        • 11.3.2.2.4. By Distribution Channel
        • 11.3.2.2.5. By End User
    • 11.3.3. UAE Eye Drop Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Drug Class
        • 11.3.3.2.3. By Disease Indication
        • 11.3.3.2.4. By Distribution Channel
        • 11.3.3.2.5. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Johnson & Johnson
  • 14.2. Bausch Health Companies, Inc.
  • 14.3. Abbott Laboratories, Inc.
  • 14.4. Alcon Inc.
  • 14.5. Allergan, Inc. (AbbVie)
  • 14.6. Bayer Corporation
  • 14.7. Genentech, Inc. (Roche)
  • 14.8. Akorn, Inc.
  • 14.9. KC Pharmaceuticals, Inc.
  • 14.10. Pfizer, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer